Chronic Pain
Study register · detail Klinische Studie · Chronic Pain · 2018

Medical Cannabis in Patients with Chronic Pain: Effect on Pain Relief, Pain Disability, and Psychological aspects. A Prospective Non randomized Single Arm Clinical Trial.

Clear benefit GRADE High 45 citations
Samplen = 338 Pat.
Duration12 months
Endpointpain intensity
Blindingoffen
DesignKlinische Studie
Cannabinoidvollspektrum
Routeoral
Key finding

Statistically significant reduction in pain intensity, pain disability as well as anxiety and depression symptoms after 12 months of cannabis therapy as an adjuvant.

Summary

Prospective single-arm study (n=338) on cannabis flos 19% decoction as add-on therapy for various chronic pain diagnoses over 12 months; statistically significant reduction in pain intensity from baseline to 12 months (χ²=61.375; p<0.001), improvements also in pain disability (χ²=39.423; p<0.001) as well as anxiety (χ²=30.362; p<0.001) and depression symptoms (χ²=27.786; p<0.001). Cannabis as an adjuvant to traditional analgesia effective for functional and psychological dimensions of chronic pain.

P
PopulationAdults with various chronic pain conditions, n=338
I
InterventionCannabis flos 19% THC as decoction, adjunctive to standard analgesia, over 12 months
O
OutcomeStatistically significant reduction in pain intensity (χ²=61,375; p<0,001), pain disability (χ²=39,423; p<0,001) as well as anxiety (χ²=30,362; p<0,001) and depression symptoms (χ²=27,786; p<0,001) after 12 months
Confidence in the evidence
High

The highest of four GRADE levels, the effect estimate is very reliable.

Quality profile
Sample size
Blinding Open-label
Effect size Clear benefit
Citations / year
Authors
Poli P, Crestani F, Salvadori C, Valenti I, Sannino C
DOI 10.7417/t.2018.2062
Design: Klinische Studie
Share
Abstract
Background: There is an increasing interest in the medical use of cannabis, particularly in the treatment of chronic pain. Objectives: The aim is to evaluate the effects of cannabis use and the associated benefits reported by patients with various chronic pain diagnoses. Material And Methods: A total of 338 patients with different chro- nic pain conditions were treated with a Cannabis Flos 19% decoction for 12 months, in addition to their pharmacological therapy. Baseline levels for pain medications, pain intensity, pain disability, anxiety and depression were recorded at 1, 3, 6 and 12 months. Results: Pain intensity records a statistically significant reduction from Baseline to 12 months follow up (X(2) 61.375; P<0,001); the im- provements from Baseline to 12 months follow up are also recorded in pain disability (X(2) 39.423; P<0,001) and in anxiety and depression symptoms (X(2)30.362; P<0,001; X(2)27.786; P<0,001). Conclusions: Our study suggest that Cannabis therapy, as an adjun- ct a traditional analgesic therapy, can be an efficacious tool to make more effective the management of chronic pain and its consequences on functional and psychological dimension. Further randomized, controlled trials are needed to confirm our conclusions.

The impediment to action advances action. — Marcus Aurelius